Bryar Bequette, PA
Medical · Washington, MONPI 1972161206
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 458 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,312 and has fallen 96.2% since, to $125 in 2024. Among medical clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 458 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$1K
- Pfizer$992
- Novartis$954
- Amgen$813
- Lilly USA, LLC$723
- plus $2K from 32 others
What the payments were for
- Food & beverage$7,94198%
- Education$1802%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 82 | $1,316 |
| Johnson & Johnson | 52 | $1,072 |
| Pfizer | 64 | $992 |
| Novartis | 56 | $954 |
| Amgen(2 entities) | 48 | $813 |
| Lilly USA, LLC | 38 | $723 |
| UCB, Inc. | 34 | $609 |
| AstraZeneca | 9 | $184 |
| Teva Pharmaceuticals USA, Inc. | 3 | $156 |
| E.r. Squibb & Sons, L.L.C. | 7 | $120 |
| Aurinia Pharma U.S., Inc. | 5 | $113 |
| Organon | 6 | $106 |
| GSK | 6 | $90 |
| Sanofi | 4 | $82 |
| Boehringer Ingelheim | 5 | $80 |
| Bioventus LLC | 1 | $70 |
| Octapharma USA, Inc. | 1 | $64 |
| Fresenius Kabi USA, LLC | 4 | $63 |
| Sandoz | 4 | $63 |
| Arbor Pharmaceuticals, Inc. | 4 | $59 |
| Merck | 3 | $42 |
| Sanofi-aventis U.S. LLC | 2 | $40 |
| Valinor Pharma, LLC | 2 | $38 |
| Genentech USA, Inc. | 2 | $33 |
| Fidia Pharma USA Inc. | 2 | $28 |
| Ferring Pharmaceuticals Inc. | 2 | $24 |
| Radius Health, Inc. | 1 | $21 |
| Biocryst US Sales Co., LLC | 1 | $20 |
| Antares Pharma, Inc. | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Virtus Pharmaceuticals LLC | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $15 |
| Celltrion USA Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Eisai Inc. | 1 | $13 |
| Medexus Pharma, Inc. | 1 | $12 |
| Athena Bioscience, LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COSENTYX$121
How this compares
$8,121 in reported general payments places this provider in the 90th percentile of 198 medical providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 22 | $1,182 |
| Leflunomide | 21 | $1,010 |
| Sulfasalazine DrSulfasalazine | 14 | $653 |
| Azathioprine | 17 | $623 |
| Prednisone | 69 | $527 |
| Gabapentin | 43 | $463 |
| MethotrexateMethotrexate Sodium | 23 | $362 |
| Diclofenac Sodium | 32 | $295 |
| Cyclobenzaprine Hcl | 30 | $183 |
| Meloxicam | 13 | $35 |
Paid to pharmacies, not to this prescriber.
Other medical in Washington
- Morgan Dillon-Van IwaardenWashington$2K
- Benjamin IngenthronWashington$2K
- Melanie ChisamSpringfield$92K
- Emily JensenBowling Green$51K
- Sarah WilmsmeyerChesterfield$22K
- Amy MosmanSaint Louis$21K
- Dustin BartlettSpringfield$21K
- Alexa Fider-WhyteSaint Louis$18K
- Megan Isaacson-SchmidSaint Louis$16K
- Erin YoffieSaint Louis$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.